In contrast, reducing MYCN levels in MYCN-amplified neuroblastoma cells or increasing MYCN in MYCN-WT neuroblastoma cells did not consistently affect the expression of other BCL-2 family proteins other than PMAIP1 (Figures S2E and S2F), nor did MYCN levels correlate with other BCL-2 family member expression in the Garnett cell line collection (Figures S2G–S2I). This evidence concerns the gene MYCN and neuroblastoma.